While other studies demonstrate the markedly increased risk for death among TB/HIV patients whose HIV is not treated when the CD4 count is ≤ 50 cells/mm3, our study suggests that benefit is derived with earlier treatment for CD4 counts that are up to 100 cells/mm3. This evidence concerns the gene CD4 and tuberculosis.